The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:1571-1573 November 23, 2000 Number 21
NextNext

Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Berlangieri, S. U.
-Related Article
by Pieterman, R. M.
To the Editor: In their study of the value of positron-emission tomography (PET) in the preoperative staging of non–small-cell lung cancer, Pieterman et al. (July 27 issue)1 found that PET was more sensitive and specific than computed tomography (CT) in detecting mediastinal metastases and that PET identified distant metastases that had not been found by standard methods in 11 of 102 patients. Of 29 "hot spots" potentially representing distant metastases, 9 were considered to be false positive results; the evaluation of such false positive findings may result in complications, increased costs, and delayed treatment.

Experience with the use of imaging . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.